Effect of Oral Vasopressors Used for Liberation from Intravenous Vasopressors in Intensive Care Unit Patients Recovering from Spinal Shock: A Randomized Controlled Trial

Table 1

Comparison between the three studied groups related to the duration of IV vasopressor requirements and ICU LOS (n = 90).

Outcomes	Control	Midodrine	Minirin	value	P1	P2	P3
	Mean ± SD	Mean ± SD	Mean ± SD
Duration of IV vasopressors requirements (days)	6.93 ± 2.32	3.3 ± 1.32	4.8 ± 1.83	<0.001	<0.001	<0.001	0.003
ICU LOS (days)	9.03 ± 3.74	5.13 ± 1.83	5.5 ± 1.91	<0.001	<0.001	<0.001	0.592 NS

One-way ANOVA tests quantitative data between the three groups or more. value, comparison between all group. P1, comparison between IV vasopressors and midodrine. P2, comparison between IV vasopressors and minirin. P3, comparison between midodrine and minirin. Significant level at value < 0.01. Ns, not significant.